Hosted on MSN22h
Piper Sandler Downgrades Amphastar Pharmaceuticals (AMPH)
Fintel reports that on February 4, 2025, Piper Sandler downgraded their outlook for Amphastar Pharmaceuticals (NasdaqGS:AMPH) ...
Piper Sandler cuts Amphastar stock rating, slashes price target
Piper Sandler adjusted its stance on Amphastar Pharmaceuticals (NASDAQ:AMPH), downgrading the company's stock rating from Overweight to Neutral and significantly reducing the price target to $36.00 ...
Amphastar downgraded to Neutral from Overweight at Piper Sandler
Piper Sandler downgraded Amphastar (AMPH) to Neutral from Overweight with a price target of $36, down from $66. The firm noted that shares of ...
Amphastar Pharmaceuticals (AMPH) Gets a Hold from Bank of America Securities
In a report released today, Jason Gerberry from Bank of America Securities reiterated a Hold rating on Amphastar Pharmaceuticals (AMPH – ...
The Armenian Reporter3d
Amphastar Pharmaceuticals, Inc. (NASDAQ:AMPH) Short Interest Up 10.3% in January
Amphastar Pharmaceuticals, Inc. (NASDAQ:AMPH – Get Free Report) was the target of a large growth in short interest during the month of January. As of January 15th, there was short interest totalling 4 ...